Your browser doesn't support javascript.
loading
High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis.
Khwaja, Jahanzaib; Bomsztyk, Joshua; Mahmood, Shameem; Wisniowski, Brendan; Shah, Raakhee; Tailor, Anish; Yong, Kwee; Popat, Rakesh; Rabin, Neil; Kyriakou, Charalampia; Sive, Jonathan; Esposti, Simona Degli; Larkin, Daniel F P; Worthington, Sarah; Hart, Alyse; Dowling, Emma; Correia, Nuno; Bygrave, Ceri; Rydzewski, Andrzej; Jamroziak, Krzysztof; Wechalekar, Ashutosh D.
Affiliation
  • Khwaja J; Department of Haematology, University College London Hospital, London, UK.
  • Bomsztyk J; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
  • Mahmood S; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
  • Wisniowski B; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK.
  • Shah R; Department of Haematology, University College London Hospital, London, UK.
  • Tailor A; Department of Haematology, University College London Hospital, London, UK.
  • Yong K; Department of Haematology, University College London Hospital, London, UK.
  • Popat R; Department of Haematology, University College London Hospital, London, UK.
  • Rabin N; Department of Haematology, University College London Hospital, London, UK.
  • Kyriakou C; Department of Haematology, University College London Hospital, London, UK.
  • Sive J; Department of Haematology, University College London Hospital, London, UK.
  • Esposti SD; Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
  • Larkin DFP; Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, UK.
  • Worthington S; Department of Haematology, University College London Hospital, London, UK.
  • Hart A; Department of Haematology, University College London Hospital, London, UK.
  • Dowling E; Department of Haematology, University College London Hospital, London, UK.
  • Correia N; Department of Haematology, University College London Hospital, London, UK.
  • Bygrave C; Department of Haematology, University Hospital of Wales, Cardiff, UK.
  • Rydzewski A; Department of Internal Medicine, Nephrology and Transplantation Medicine, Central Clinical Hospital of the Ministry of Internal Affairs, Warsaw, Poland.
  • Jamroziak K; Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
  • Wechalekar AD; National Amyloidosis Centre, University College London (Royal Free Campus), London, UK. a.wechalekar@ucl.ac.uk.
Blood Cancer J ; 12(9): 128, 2022 09 05.
Article in En | MEDLINE | ID: mdl-36064540
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin Light-chain Amyloidosis / Multiple Myeloma Limits: Humans Language: En Journal: Blood Cancer J Year: 2022 Document type: Article Affiliation country: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin Light-chain Amyloidosis / Multiple Myeloma Limits: Humans Language: En Journal: Blood Cancer J Year: 2022 Document type: Article Affiliation country: Reino Unido